Pharmaxis Ltd's market cap is currently ―. The company's EPS TTM is AU$-0.017; its P/E ratio is -1.57; Pharmaxis Ltd is scheduled to report earnings on February 8, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 8.94M	AU$ 18.71M	AU$ 14.76M	AU$ 31.12M	AU$ 31.07M
Total Assets	AU$ 25.19M	AU$ 33.59M	AU$ 35.42M	AU$ 52.67M	AU$ 50.10M
Total Debt	AU$ 4.29M	AU$ 6.32M	AU$ 8.15M	AU$ 7.17M	AU$ 8.27M
Net Debt	AU$ -4.65M	AU$ -12.39M	AU$ -6.61M	AU$ -23.95M	AU$ -22.80M
Total Liabilities	AU$ 14.38M	AU$ 30.75M	AU$ 33.98M	AU$ 37.85M	AU$ 38.98M
Stockholders Equity	AU$ 10.80M	AU$ 2.85M	AU$ 1.43M	AU$ 14.81M	AU$ 11.12M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Pharmaxis Ltd Earnings and Revenue History

Income Statement >

Pharmaxis Ltd Debt to Assets

Balance Sheet >

Pharmaxis Ltd Cash Flow

Cash Flow >

Pharmaxis Ltd Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing